Literature DB >> 33799594

Predictive Genetic Variations in the Kynurenine Pathway for Interferon-α-Induced Depression in Patients with Hepatitis C Viral Infection.

Szu-Wei Cheng1,2, Jing-Xing Li1,2, Daniel Tzu-Li Chen2,3,4, Yu-Chuan Chien2,3, Jane Pei-Chen Chang1,2, Shih-Yi Huang5, Piotr Galecki6, Kuan-Pin Su1,2,3,7.   

Abstract

Importance: The high incidence of major depressive episodes during interferon-α (IFN-α) therapy is considered the most powerful supportive evidence for the inflammation theory of depression. As the kynurenine pathway plays an important role connecting inflammation and depression, it is plausible to investigate this pathway for predictive genetic markers for IFN-α-induced depression.
Methods: In this prospective case-control study, we assessed 291 patients with chronic hepatitis C viral infection taking IFN-α therapy and analyzed the single nucleotide polymorphisms (SNPs) in genes in the kynurenine pathway. Our case group contained patients who developed IFN-α-induced depression during the treatment, and others were defined as the control group. Genomic DNA was extracted from leukocytes in the peripheral blood and analyzed by Affymetrix TWB array. We first tested allelic, dominant, and recessive models on each of our SNPs using Fisher's exact test. We then conducted 5000 gene-wide max(T) permutations based on the best model of each SNP to provide strong gene-wide family-wise error rate control. Finally, we preformed logistic regression for the significant SNPs acquired in previous procedures, with sex and education level as covariates to build predictive models. Additional haplotype analyses were conducted with Haploview 4.2 to investigate the combining effect of multiple significant SNPs within a gene.
Results: With sex and education level as covariates, rs8082252 (p = 0.0015, odds ratio = 2.716), rs8082142 (p = 0.0031, odds ratio = 2.499) in arylformamidase (AFMID), and rs12477181 (p = 0.0004, odds ratio = 0.3478) in kynureninase (KYNU) were significant in logistic regression models with dominant modes of inheritance. Haplotype analyses showed the two significant SNPs in AFMID to be in the same haploblock and highly correlated (r2 = 0.99). There were two significant haplotypes (by the sequence of rs8082252, rs8082142): AT (χ2 = 7.734, p = 0.0054) and GC (χ2 = 6.874, p = 0.0087). Conclusions: This study provided supportive evidence of the involvement of the kynurenine pathway in IFN-α-induced depression. SNPs in this pathway were also predictive of this disease.

Entities:  

Keywords:  AFMID; KYNU; interferon-α-induced depression; kynurenine pathway

Year:  2021        PMID: 33799594      PMCID: PMC7998192          DOI: 10.3390/jpm11030192

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  56 in total

1.  The heterogeneity of "major depression".

Authors:  David Goldberg
Journal:  World Psychiatry       Date:  2011-10       Impact factor: 49.548

2.  Genetic Variations of Ionotropic Glutamate Receptor Pathways on Interferon-α-induced Depression in Patients with Hepatitis C Viral Infection.

Authors:  Szu-Wei Cheng; Jing-Xing Li; Yu-Chuan Chien; Jane Pei-Chen Chang; Sergey Shityakov; Shih-Yi Huang; Piotr Galecki; Kuan-Pin Su
Journal:  Brain Behav Immun       Date:  2020-11-06       Impact factor: 7.217

3.  Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced antichlamydial indoleamine dioxygenase activity independently.

Authors:  A R Currier; M H Ziegler; M M Riley; T A Babcock; V P Telbis; J M Carlin
Journal:  J Interferon Cytokine Res       Date:  2000-04       Impact factor: 2.607

4.  Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain.

Authors:  S Abe; T Hori; T Suzuki; A Baba; H Shiraishi; T Yamamoto
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

5.  Depression-free after Interferon-α exposure indicates less incidence of depressive disorder: A longitudinal study in Taiwan.

Authors:  Ching-Fang Sun; Wei-Che Chiu; Pau-Chung Chen; Hui-Chih Chang; Ta-Wei Guu; Sergey Shityakov; Andrew H Miller; Jennifer C Felger; Jane Pei-Chen Chang; Kuan-Pin Su
Journal:  Brain Behav Immun       Date:  2020-05-17       Impact factor: 7.217

6.  IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.

Authors:  M C Wichers; G H Koek; G Robaeys; R Verkerk; S Scharpé; M Maes
Journal:  Mol Psychiatry       Date:  2005-06       Impact factor: 15.992

7.  The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction.

Authors:  Christian Klein; Christine Patte-Mensah; Omar Taleb; Jean-Jacques Bourguignon; Martine Schmitt; Frédéric Bihel; Michel Maitre; Ayikoe G Mensah-Nyagan
Journal:  Neuropharmacology       Date:  2013-02-17       Impact factor: 5.250

Review 8.  From inflammation to sickness and depression: when the immune system subjugates the brain.

Authors:  Robert Dantzer; Jason C O'Connor; Gregory G Freund; Rodney W Johnson; Keith W Kelley
Journal:  Nat Rev Neurosci       Date:  2008-01       Impact factor: 34.870

9.  Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.

Authors:  Linn Fagerberg; Björn M Hallström; Per Oksvold; Caroline Kampf; Dijana Djureinovic; Jacob Odeberg; Masato Habuka; Simin Tahmasebpoor; Angelika Danielsson; Karolina Edlund; Anna Asplund; Evelina Sjöstedt; Emma Lundberg; Cristina Al-Khalili Szigyarto; Marie Skogs; Jenny Ottosson Takanen; Holger Berling; Hanna Tegel; Jan Mulder; Peter Nilsson; Jochen M Schwenk; Cecilia Lindskog; Frida Danielsson; Adil Mardinoglu; Asa Sivertsson; Kalle von Feilitzen; Mattias Forsberg; Martin Zwahlen; IngMarie Olsson; Sanjay Navani; Mikael Huss; Jens Nielsen; Fredrik Ponten; Mathias Uhlén
Journal:  Mol Cell Proteomics       Date:  2013-12-05       Impact factor: 5.911

Review 10.  Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem.

Authors:  Ekta Franscina Pinto; Chittaranjan Andrade
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

View more
  1 in total

1.  Identification of Genetic Variations in the NAD-Related Pathways for Patients with Major Depressive Disorder: A Case-Control Study in Taiwan.

Authors:  Daniel Tzu-Li Chen; Szu-Wei Cheng; Tiffany Chen; Jane Pei-Chen Chang; Bing-Fang Hwang; Hen-Hong Chang; Eric Y Chuang; Che-Hong Chen; Kuan-Pin Su
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.